drugset / Trial / NCT06301828
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, prospective, exploratory clinical study to evaluate the efficacy and safety of endostar combined with stereotactic body radiation therapy (SBRT) and Envafolimab in patients with advanced gastrointestinal cancer after multi-line treatment.
Timeline
- Start
- 2024-02-21
- Primary completion
- 2025-06-21
- Completion
- 2026-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | — | — |
| Subject | Envafolimab | Monoclonal antibody | — | — |